Evolving Patterns of <scp>EBV</scp> ‐Associated <scp>PTLD</scp> After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter <scp>GETH</scp> ‐ <scp>TC</scp> Study

EBV + PTLD frequency has declined in Spain. Prognosis remains poor for rituximab non-responders, highlighting limited access to EBV-specific cellular therapies as an unmet need.

Authors

Institutions

Publication Details

Journal
European Journal Of Haematology
Published
2026-01-07
DOI
https://doi.org/10.1111/ejh.70109
Primary Topic
Viral-associated cancers and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evolving Patterns of EBV ‐Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH ‐ TC Study

Lucía García Tomás, Pedro Chorão, María Luisa López Huguet, Júlia Marsal et al.
European Journal Of Haematology
Viral-associated cancers and disorders
article

Evolving Patterns of EBV ‐Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH ‐ TC Study

Lucía García Tomás, Pedro Chorão, María Luisa López Huguet, Júlia Marsal, D Galan Gil, A. Callejo Perez, Pascual Balsalobre, María Suárez‐Lledó, Silvia Filaferro, Lucrecia Yáñez, Rodrigo Bronze Martino, Paula Sánchez, Javier López, Lourdes Vázquez, Ana Jiménez Ubieto, Irene García‐Cadenas, Marta González‐Vicent, Mireia Micó‐Cerdà, Pablo Silva, Francisco Martin, Amaya Zabalza, Manuel Guerreiro, J. L. Piñana, Noelia Romero
article en

Abstract

EBV + PTLD frequency has declined in Spain. Prognosis remains poor for rituximab non-responders, highlighting limited access to EBV-specific cellular therapies as an unmet need.

European Journal Of HaematologyVol. 116(4)
European Organisation for Research and Treatment of Cancer (NL), Hospital Sant Joan de Déu Barcelona (ES), Hospital de Sant Pau (ES), Hospital General Universitario Gregorio Marañón (ES), Research Institute Hospital 12 de Octubre (ES), Hospital General Universitario Morales Meseguer (ES), Hospital Clínico Universitario de Valencia (ES), Complejo Hospitalario de Navarra (ES), Grupo Español de Trasplante Hematopoyético y Terapia Celular (ES), Complejo Hospitalario de Salamanca (ES), Marqués de Valdecilla University Hospital (ES), Hospital Infantil Universitario Niño Jesús (ES), Hospital Clínic de Barcelona (ES), Leitat Technological Center (ES), Hospital Universitario Reina Sofía (ES), Vall d'Hebron Hospital Universitari (ES), Hospital Universitario Virgen del Rocío (ES), Hospital Universitari Germans Trias i Pujol (ES), Hospital Universitario Ramón y Cajal (ES), Universidad de Navarra (ES)
Good health and well-being
Openalex Percentile: Top 97%
Viral-associated cancers and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.